Compare VUZI & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VUZI | CDXS |
|---|---|---|
| Founded | 1997 | 2002 |
| Country | United States | United States |
| Employees | 88 | N/A |
| Industry | Industrial Machinery/Components | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.9M | 256.3M |
| IPO Year | 2009 | 2008 |
| Metric | VUZI | CDXS |
|---|---|---|
| Price | $2.62 | $1.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 828.6K | ★ 1.5M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | 43.82 |
| EPS | ★ N/A | N/A |
| Revenue | $6,280,611.00 | ★ $138,590,000.00 |
| Revenue This Year | $103.32 | $7.73 |
| Revenue Next Year | N/A | $14.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 9.14 | ★ 32.30 |
| 52 Week Low | $1.83 | $0.96 |
| 52 Week High | $5.62 | $3.12 |
| Indicator | VUZI | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.52 | 41.88 |
| Support Level | $2.31 | $1.57 |
| Resistance Level | $2.79 | $1.75 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 79.74 | 89.29 |
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices and third-party original design manufacturer (ODM) and original equipment manufacturer (OEM) devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.